Catalysing Change
in the Chemical Industry

Creating Economic and Environmental Value Through Enzyme Technology

WHAT WE DO

Ligo is using generative diffusion models for enzyme design. Our models have spatial understanding, allowing us to generate enzymes which have higher precision, stability and activity.

We are working to commercialise our models in a range of industries including pharmaceutical, detergent, fragrance, and agricultural chemical manufacturing.

1

Reaction Selection

Firstly we evaluate the mechanism of the reaction and select optimal enzymatic pathways

2

Enzyme Modelling

We use in house tools to model the enzyme-ligand structure

3

Ligo AI

We then feed structural and evolutionary data in to our enzyme design system.

The new enzyme has higher stability, increased catalytic activity, and unique intellectual property.  

Coming Soon

De novo enzyme design

Our new diffusion model takes the transition state as input and generates entirely new enzymes using spatial understanding

WAIT LIST

OUR PROJECTS

Agriculture

Enzymes are used throughout agriculture for the production of herbicides, pesticides and animal feed. We have used our technology to redesign phytase, an enzyme used to improve the phosphate content of animal feed. This previously took many years for agricultural companies to optimise and we were able to redesign and validate phytase in a matter of days

Biomining

Many of the Earth's precious minerals are trapped in ores that cannot be mined using traditional methods due to feasibility and regulation. One of our current projects is to design new enzymes which liberate lithium from its ore.

Carbon Capture

Carbon capture will be an essential technology in reaching urgent climate goals. Many of todays biological based carbon capture technologies are limited by the enzymatic pathways involved in natural carbon removal systems. By engineering enzymes we are looking to overcome these barriers.

Pharma  Manufacturing

Pharmaceutical manufacturers have been turning to enzymes to reduce the cost of drug manufacturing. However, enzyme design has previously taken years and huge investment. We are creating enzymatic cascades for APIs at a fraction of the cost and time.

Biomining

Many of the Earth's precious minerals are trapped in ores that cannot be mined using traditional methods due to feasibility and regulation. One of our current projects is to design new enzymes which liberate lithium from its ore.

Carbon Capture

Carbon capture will be an essential technology in reaching urgent climate goals. Many of todays biological based carbon capture technologies are limited by the enzymatic pathways involved in natural carbon removal systems. By engineering enzymes we are looking to overcome these barriers.

Pharma  Manufacturing

Pharmaceutical manufacturers have been turning to enzymes to reduce the cost of drug manufacturing. However, enzyme design has previously taken years and huge investment. We are creating enzymatic cascades for APIs at a fraction of the cost and time.

the team
CEO and Co-founder, Ed, thrives at the intersection between computer science and biology. Ed studied computer science at Princeton before transferring to Oxford Medical School. Here, he worked in three synthetic biology labs gaining skills in genetic engineering and computational modelling. Before Oxford Ed started his first company in Guadalajara, Mexico, which now does $1.2M in annual sales.
Edward Harris
CEO
CSO and Co-founder, Emily, was ranked as one of the top biochemists from Oxford University. Emily is an experienced wet lab scientist with previous experience running strain engineering and chemostasis experiments at CyanoCapture, and vaccine research at InventPrise. Emily is leading our lab based experiments in partnership with our CROs.
Emily Egerton-Warburton
CSO
CTO and Co-Founder, Arda, studied cell and systems biology at Oxford where became a Google Cloud Research Innovator for his work in computational biology. Alongside building our foundational enzyme design model, he has recently open-sourced an implementation of Google Deepmind's AlphaFold3.
Arda Goreci
CTO